25 reports

  • MARKET OUTLINE

Endoscopy cameras segment accounts for a major share owing to its widespread usage in diagnostic and therapeutic applications in fields of gastrointestinal (GI) endoscopy, laparoscopy, arthroscopy, laryngoscopy, bronchoscopy, and many other diagnostic and therapeutic procedures.

  • Camera
  • Dermatology
  • Market Size
  • Olympus Corporation
  • Stryker Corporation
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, CO-DEVELOPMENT DEALS, 2006-2017 (PART
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS FOR

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using Metolate.

  • Dermatology
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.

ORAL MEDICATIONS THAT INCLUDE ANTIBIOTICS AND RETINOIDS HAVE LED TO INCREASED HEPATOTOXICITY, GASTROINTESTINAL ISSUES AND SUICIDAL TENDENCIES, ALONG WITH THE ABOVE MENTIONED ISSUES.

  • Dermatology
  • World
  • Forecast
  • Allergan plc
  • Valeant Pharmaceuticals International, Inc.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, CO-DEVELOPMENT DEALS, 2006-2016
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, OVERALL PHARMACEUTICAL INDUSTRY

Minor AEs such as stomatitis, headaches, fatigue and gastrointestinal problems such as nausea and vomiting may occur when using methotrexate.

  • Dermatology
  • World
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • Dermatology Therapeutics Market, Global, Overall
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting ORAI1, 2017

It is also in development for various indications in the gastrointestinal, respiratory, and ophthalmology therapy areas.

  • Dermatology
  • World
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.
  • Research Contact: info@globaldata.com

The gastrointestinal therapeutics market recorded ## partnership deals and six licensing deals worth USD##. ## billion in Q## 2016.

  • Dermatology
  • Endocrine Disease
  • World
  • Deals & Alliance
  • AstraZeneca PLC
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017 (CONTD..1), H1 2017

NA : Not Available Source: Global Markets Direct RECOMBINANT PROTEIN FOR SCAR - DRUG PROFILE RECOMBINANT PROTEIN TO ANTAGONIZE TGF BETA FOR IMMUNOLOGY, DERMATOLOGY, GASTROINTESTINAL AND MUSCULOSKELETAL DISORDERS - DRUG PROFILE RXI-## - DRUG PROFILE ## resulted in dose-dependent silencing

  • Dermatology
  • Hospital
  • United States
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • Lee's Pharmaceutical Holdings Ltd, Deals By Therapy Area, 2011 to YTD 2017

The company offers a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabolic diseases; and others.

  • Dermatology
  • Ophthalmology
  • Pharmaceutical
  • China
  • GlobalData's company
  • Maruho Acquires Dermatology Company, Cutanea Life Sciences

The company also offers products for infectious disease, ear nose throat disorders, ophthalmology, musculoskeletal disorders, central nervous system (CNS) disorders, cardiovascular, gastrointestinal and other diseases.

  • Dermatology
  • Pharmaceutical
  • Japan
  • United States
  • Maruho Co., Ltd.
  • Valeant Pharmaceuticals International Inc, Deals By Therapy Area, 2011 to YTD 2017

Carolyn Logan, president and CEO, Salix, said, " We believe gastrointestinal-specific oral antibiotic rifaximin has the potential to treat numerous gastrointestinal diseases.

  • Dermatology
  • Canada
  • United States
  • M&A
  • Valeant Pharmaceuticals International, Inc.

Endoscopic data reflect the ability of Brilacidin to help clear Gastrointestinal (GI) tract mucosa in patients suffering from ulcerative colitis.

  • Anti-Infective
  • Dermatology
  • Pharmaceutical
  • United States
  • Product Initiative

The company also offers products for infectious disease, ear nose throat disorders, ophthalmology, musculoskeletal disorders, central nervous system (CNS) disorders, cardiovascular, gastrointestinal and other diseases.

  • Dermatological Condition
  • Dermatology
  • United States
  • Company
  • Dermira, Inc.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Dermatology
  • United States
  • Product Initiative
  • Supply
  • Dermira, Inc.

Endoscopic data reflect the ability of Brilacidin to help clear Gastrointestinal (GI) tract mucosa in patients suffering from ulcerative colitis.

  • Dermatology
  • Hospital
  • United States
  • Product Initiative
  • Cellceutix Corporation

Gastrointestinal Tract Cancer, Inflammation, Inflammatory Bowel Disease, Inflammatory Pain, Lung Cancer, Osteoarthritis Pain Planned Phase I/ II Interventional AAT-## AskAt Inc.

  • Dermatological Condition
  • Dermatology
  • Pathology
  • World
  • Product Initiative
  • VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (FORMERLY BIOVAIL CORPORATION)
  • COMPANY OVERVIEW AND KEY FACTS

Salix is a US-based pharmaceutical company focused on treatment of gastrointestinal diseases, while Dr.

  • Dermatology
  • United States
  • Company
  • M&A
  • Valeant Pharmaceuticals International, Inc.

Gastrointestinal Disorders Completed Phase I Interventional CNDO-## Beth Israel Deaconess Medical Center Inc Food Allergy Initiative ## Feb 2010 ## Dec 2011 ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Statu

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trial profile. 155 Trial Title
  • Clinical Trial Profile Snapshots

Gastrointestinal Tumor, Trauma (CD##/ CD##, Interleukin ## (T Cell Growth Factor or Aldesleukin or IL##), Interleukin ## (B Cell Stimulatory Factor ## or Binetrakin or Lymphocyte Stimulatory Factor ## or Pitrakinra or IL##), Natural Killer (NK) Cell, T Cell Surface Glycoprotein CD## (T Cell Surf

  • Dermatology
  • Hospital
  • Therapy
  • World
  • Product Initiative

Gastrointestinal Disorders, Peanut Allergy, Pruritus, Rhino-Conjunctivitis Completed Phase I Interventional CNDO-## Beth Israel Deaconess Medical Center, Inc.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative

It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women' s health, infectious disease, cardiovascular, respiratory, immunology, gastrointestinal, oncology, nutrition, toxicology, and mouth and denta

  • Dermatology
  • Healthcare
  • Wound Care
  • United States
  • Product Initiative

The company intends to use the proceeds to add more data analysis to its products and move into new specialty areas including gastrointestinal care, ENT care and rheumatology.

  • Dermatology
  • Patient Data Management
  • United States
  • Company
  • Modernizing Medicine, Inc.

gastrointestinal disorder, eye health, neurology and branded generics.

  • Dermatology
  • United States
  • Company
  • M&A
  • Valeant Pharmaceuticals International, Inc.

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Dermatology
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative

Gastrointestinal Tract Cancer, Inflammation, Inflammatory Bowel Disease, Inflammatory Pain, Lung Cancer, Osteoarthritis Pain Planned Phase I/ II Interventional AAT-## AskAt Inc.

  • Clinical Trial
  • Dermatological Condition
  • Dermatology
  • World
  • Novartis AG

The company focuses on pharmaceutical products in therapeutics, including prescription drugs for gastrointestinal, respiratory, and cardiovascular indications, as well as on OTC medication.

  • Dermatology
  • United States
  • Corporate Finance
  • M&A
  • Peplin, Inc.